Follicular lymphoma with a predominantly diffuse growth pattern with 1p36 deletion: a clinicopathologic analysis of eight cases.
10.3760/cma.j.cn112151-20230905-00130
- Author:
J ZHOU
1
;
J L XIE
2
;
X G ZHOU
2
;
X J ZHOU
1
;
Q X XIA
1
Author Information
1. Department of Pathology, the Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou 450008, China.
2. Department of Pathology, Beijing Friendship Hospital, Capital Medical University, Beijing 100020, China.
- Publication Type:Journal Article
- MeSH:
Male;
Female;
Humans;
Aged;
Lymphoma, Follicular/pathology*;
In Situ Hybridization, Fluorescence;
Lymphoma, B-Cell/pathology*;
Chromosome Deletion;
Cell Proliferation
- From:
Chinese Journal of Pathology
2024;53(1):34-39
- CountryChina
- Language:Chinese
-
Abstract:
Objective: To investigate the clinical and pathologic features and diagnosis of follicular lymphoma (FL) with a predominantly diffuse growth pattern (DFL) with 1p36 deletion. Methods: Eight cases of DFL with 1p36 deletion diagnosed at Department of Pathology, Beijing Friendship Hospital, Capital Medical University (n=5) and the Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital (n=3) from January 2017 to January 2023 were included. Their clinicopathologic features and follow-up data were analyzed. Immunohistochemistry and fluorescence in situ hybridization (FISH) were performed. Results: There were five males and three females, with a median age of 67 years, and inguinal lymphadenopathy was found as the main symptom. Histologically, similar morphologic features were sheared among all cases, with effaced nodal structure and characterized by proliferation of centrocytes in a diffuse pattern, with or without follicular components. The germinal center-related markers such as CD10 and/or bcl-6 were expressed in the tumor cells, and 1p36 deletion but not bcl-2 translocation was appreciable in these cases. Conclusions: DFL with 1p36 deletion is a rare subtype of FL, with some overlaps with other types of FL or indolent B-cell lymphomas in their pathologic features. An accurate diagnosis requires comprehensive considerations based on their clinical, pathologic, immunohistochemical, and molecular features.
